{"id":20194,"date":"2021-10-21T14:35:00","date_gmt":"2021-10-21T13:35:00","guid":{"rendered":"https:\/\/www.ersnet.org\/?p=20194"},"modified":"2021-10-27T14:47:03","modified_gmt":"2021-10-27T13:47:03","slug":"discontinuing-treatment-community-acquired-pneumonia","status":"publish","type":"post","link":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/","title":{"rendered":"Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":53,"featured_media":20242,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_oasis_is_in_workflow":0,"_oasis_original":0,"_oasis_task_priority":"2normal","footnotes":""},"categories":[109,25,61],"tags":[],"class_list":["post-20194","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-respiratory-patient-care","category-respiratory-digests","category-respiratory-infections"],"acf":[],"yoast_head":"\nDiscontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial - ERS - European Respiratory Society<\/title>\n<meta name=\"description\" content=\"ERS is an international membership organisation that unites physicians, health professionals, scientists and other experts working in respiratory medicine.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial - ERS - European Respiratory Society\" \/>\n<meta property=\"og:description\" content=\"ERS is an international membership organisation that unites physicians, health professionals, scientists and other experts working in respiratory medicine.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/\" \/>\n<meta property=\"og:site_name\" content=\"ERS - European Respiratory Society\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-21T13:35:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-27T13:47:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/10\/Pneumonia.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"E-learning ERS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"E-learning ERS\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/\"},\"author\":{\"name\":\"E-learning ERS\",\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/person\/80834f78e000c4b4e452fb2c52fe9fcd\"},\"headline\":\"Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial\",\"datePublished\":\"2021-10-21T13:35:00+00:00\",\"dateModified\":\"2021-10-27T13:47:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/\"},\"wordCount\":21,\"publisher\":{\"@id\":\"https:\/\/www.ersnet.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/10\/Pneumonia.png\",\"articleSection\":[\"General respiratory patient care\",\"Respiratory digests\",\"Respiratory infections\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/\",\"url\":\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/\",\"name\":\"Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial - ERS - European Respiratory Society\",\"isPartOf\":{\"@id\":\"https:\/\/www.ersnet.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/10\/Pneumonia.png\",\"datePublished\":\"2021-10-21T13:35:00+00:00\",\"dateModified\":\"2021-10-27T13:47:03+00:00\",\"description\":\"ERS is an international membership organisation that unites physicians, health professionals, scientists and other experts working in respiratory medicine.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#primaryimage\",\"url\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/10\/Pneumonia.png\",\"contentUrl\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/10\/Pneumonia.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ersnet.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Respiratory digests\",\"item\":\"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ersnet.org\/#website\",\"url\":\"https:\/\/www.ersnet.org\/\",\"name\":\"ERS - European Respiratory Society\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ersnet.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ersnet.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ersnet.org\/#organization\",\"name\":\"European Respiratory Society - ERS\",\"url\":\"https:\/\/www.ersnet.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/01\/ERS-logo-full.png\",\"contentUrl\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/01\/ERS-logo-full.png\",\"width\":871,\"height\":253,\"caption\":\"European Respiratory Society - ERS\"},\"image\":{\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/person\/80834f78e000c4b4e452fb2c52fe9fcd\",\"name\":\"E-learning ERS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff6ee262cfcd71195d6929c6a46c63319b9e4c36b47d442ff934e993e857f351?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff6ee262cfcd71195d6929c6a46c63319b9e4c36b47d442ff934e993e857f351?s=96&d=mm&r=g\",\"caption\":\"E-learning ERS\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial - ERS - European Respiratory Society","description":"ERS is an international membership organisation that unites physicians, health professionals, scientists and other experts working in respiratory medicine.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/","og_locale":"en_GB","og_type":"article","og_title":"Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial - ERS - European Respiratory Society","og_description":"ERS is an international membership organisation that unites physicians, health professionals, scientists and other experts working in respiratory medicine.","og_url":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/","og_site_name":"ERS - European Respiratory Society","article_published_time":"2021-10-21T13:35:00+00:00","article_modified_time":"2021-10-27T13:47:03+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/10\/Pneumonia.png","type":"image\/png"}],"author":"E-learning ERS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"E-learning ERS"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#article","isPartOf":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/"},"author":{"name":"E-learning ERS","@id":"https:\/\/www.ersnet.org\/#\/schema\/person\/80834f78e000c4b4e452fb2c52fe9fcd"},"headline":"Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial","datePublished":"2021-10-21T13:35:00+00:00","dateModified":"2021-10-27T13:47:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/"},"wordCount":21,"publisher":{"@id":"https:\/\/www.ersnet.org\/#organization"},"image":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/10\/Pneumonia.png","articleSection":["General respiratory patient care","Respiratory digests","Respiratory infections"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/","url":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/","name":"Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial - ERS - European Respiratory Society","isPartOf":{"@id":"https:\/\/www.ersnet.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#primaryimage"},"image":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/10\/Pneumonia.png","datePublished":"2021-10-21T13:35:00+00:00","dateModified":"2021-10-27T13:47:03+00:00","description":"ERS is an international membership organisation that unites physicians, health professionals, scientists and other experts working in respiratory medicine.","breadcrumb":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#primaryimage","url":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/10\/Pneumonia.png","contentUrl":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/10\/Pneumonia.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/discontinuing-treatment-community-acquired-pneumonia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ersnet.org\/"},{"@type":"ListItem","position":2,"name":"Respiratory digests","item":"https:\/\/www.ersnet.org\/news-and-features\/respiratory-digests\/"},{"@type":"ListItem","position":3,"name":"Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial"}]},{"@type":"WebSite","@id":"https:\/\/www.ersnet.org\/#website","url":"https:\/\/www.ersnet.org\/","name":"ERS - European Respiratory Society","description":"","publisher":{"@id":"https:\/\/www.ersnet.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ersnet.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.ersnet.org\/#organization","name":"European Respiratory Society - ERS","url":"https:\/\/www.ersnet.org\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.ersnet.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/01\/ERS-logo-full.png","contentUrl":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/01\/ERS-logo-full.png","width":871,"height":253,"caption":"European Respiratory Society - ERS"},"image":{"@id":"https:\/\/www.ersnet.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.ersnet.org\/#\/schema\/person\/80834f78e000c4b4e452fb2c52fe9fcd","name":"E-learning ERS","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.ersnet.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff6ee262cfcd71195d6929c6a46c63319b9e4c36b47d442ff934e993e857f351?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff6ee262cfcd71195d6929c6a46c63319b9e4c36b47d442ff934e993e857f351?s=96&d=mm&r=g","caption":"E-learning ERS"}}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/posts\/20194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/users\/53"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/comments?post=20194"}],"version-history":[{"count":3,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/posts\/20194\/revisions"}],"predecessor-version":[{"id":20243,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/posts\/20194\/revisions\/20243"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/media\/20242"}],"wp:attachment":[{"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/media?parent=20194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/categories?post=20194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/tags?post=20194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}